The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.

Dinçbaş F., Oksüz D., Atalar B., Altug T., Ilvan S., Gedik N., ...Daha Fazla

Medical oncology (Northwood, London, England), cilt.26, ss.402-8, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s12032-008-9136-1
  • Dergi Adı: Medical oncology (Northwood, London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.402-8
  • Anahtar Kelimeler: Pelvic radiotherapy, Amifostine, Gemcitabine, Late normal tissue toxicity, ADVANCED PANCREATIC-CANCER, TWICE-WEEKLY GEMCITABINE, PHASE-I, RADIATION-THERAPY, CONCURRENT GEMCITABINE, RANDOMIZED-TRIAL, RECTAL-CANCER, WR-2721, CARCINOMA, TOXICITY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır